A molecular switch for neuroprotective astrocyte reactivity

Evan G. Cameron,Michael Nahmou,Anna B. Toth,Lyong Heo,Bogdan Tanasa,Roopa Dalal,Wenjun Yan,Pratima Nallagatla,Xin Xia,Sarah Hay,Cara Knasel,Travis L. Stiles,Christopher Douglas,Melissa Atkins,Catalina Sun,Masoumeh Ashouri,Minjuan Bian,Kun-Che Chang,Kristina Russano,Sahil Shah,Mollie B. Woodworth,Joana Galvao,Ramesh V. Nair,Michael S. Kapiloff,Jeffrey L. Goldberg
DOI: https://doi.org/10.1038/s41586-023-06935-3
IF: 64.8
2023-12-13
Nature
Abstract:The intrinsic mechanisms that regulate neurotoxic versus neuroprotective astrocyte phenotypes and their effects on central nervous system (CNS) degeneration and repair remain poorly understood. Here, we show injured white matter astrocytes differentiate into two distinct C3-positive and C3-negative reactive populations, previously simplified as neurotoxic (A1) and neuroprotective (A2) 1,2 , which can be further subdivided into unique subpopulations defined by proliferation and differential gene expression signatures. We find the balance of neurotoxic versus neuroprotective astrocytes is regulated by discrete pools of compartmented cAMP derived from soluble adenylyl cyclase (sAC) and show proliferating neuroprotective astrocytes inhibit microglial activation and downstream neurotoxic astrocyte differentiation to promote retinal ganglion cell (RGC) survival. Finally, we report a new, therapeutically tractable viral vector to specifically target optic nerve head astrocytes and show elevating nuclear or depleting cytoplasmic cAMP in reactive astrocytes inhibits deleterious microglial/macrophage cell activation and promotes RGC survival after optic nerve injury. Thus, soluble adenylyl cyclase and compartmented, nuclear- and cytoplasmic-localized cAMP in reactive astrocytes act as a molecular switch for neuroprotective astrocyte reactivity that can be targeted to inhibit microglial activation and neurotoxic astrocyte differentiation to therapeutic effect. These data expand upon and define new reactive astrocyte subtypes and represent a novel step toward the development of gliotherapeutics for the treatment of glaucoma and other optic neuropathies.
multidisciplinary sciences
What problem does this paper attempt to address?